UBS Adjusts Price Target on Clover Health Investments to $5.50
UBS has raised its price target for Clover Health Investments, Corp. from $5.00 to $5.50 while maintaining a Neutral rating.
Stocks · News reference
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analysts initiated coverage: BMO rated Astera Labs Outperform with a $375 target; Citi rated ATI Buy with a $229 target.
Ormat Technologies Q3 2026 Earnings Call Transcript
Ormat Technologies (NYSE:ORA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
Lakewood-Amedex Biotherapeutics Completes Redemption of Series C Convertible Preferred Stock
Lakewood-Amedex Biotherapeutics Inc. has finalized the redemption of all remaining outstanding shares of its Series C Convertible Preferred Stock.
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics, Inc. granted equity awards to a new employee as a material inducement for their employment.
Rubrik's 'Authorized Intelligence' Podcast Joins N2K CyberWire Network
Rubrik's podcast, Authorized Intelligence, has joined the N2K CyberWire network.